Complete Pathologic Response After Concurrent Treatment with Pembrolizumab and Radiotherapy in Metastatic Colorectal Cancer: A Case Report
Jian Yang,1 Feng Bi,2 Hongfeng Gou1 1West China Hospital, Sichuan University, Chengdu, Sichuan Province, 610041, People’s Republic of China; 2Department of Medical Oncology, Laboratory of Molecular Targeted Therapy in Oncology, State Key Laboratory of Biotherapy, West China Hospital, Sichu...
Main Authors: | Yang J, Bi F, Gou H |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2021-04-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/complete-pathologic-response-after-concurrent-treatment-with-pembroliz-peer-reviewed-article-OTT |
Similar Items
-
Complete Pathologic Responses With Immunotherapy in Metastatic Renal Cell Carcinoma: Case Reports
by: Matthew D. Tucker, et al.
Published: (2020-12-01) -
Complete Pathological Response to Neoadjuvant Pembrolizumab in a Patient With Chemoresistant Upper Urinary Tract Urothelial Carcinoma: A Case Report
by: Daiki Ikarashi, et al.
Published: (2020-09-01) -
Pembrolizumab and palliative radiotherapy in 2 cases of refractory mycosis fungoides
by: Christina J. Walker, MD, et al.
Published: (2021-01-01) -
Complete remission of advanced lung adenocarcinoma with first-line pembrolizumab monotherapy: Two case reports
by: Kazuki Gohara, et al.
Published: (2021-01-01) -
A phase I/II trial of fixed-dose stereotactic body radiotherapy with sequential or concurrent pembrolizumab in metastatic urothelial carcinoma: evaluation of safety and clinical and immunologic response
by: Nora Sundahl, et al.
Published: (2017-06-01)